Inflammatory and insulinemic dietary patterns: Influence on circulating biomarkers and prostate cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) cohort.

被引:0
|
作者
Aroke, Desmond
Folefac, Edmund
Jin, Qi
Shi, Ni
Clinton, Steven K.
Tabung, Fred
机构
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Med Oncol, Comprehens Canc Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA
[4] Ohio State Univ, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17561
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Adherence to the Diabetes Risk Reduction Diet and Bladder Cancer Risk in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cohort
    Chen, Yuanhao
    Zeng, Song
    Jiao, Binbin
    Zhang, He
    Li, Gao
    Zhang, Xin
    Hu, Xiaopeng
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12) : 1726 - 1733
  • [22] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [23] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [24] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Catherine A. McCarty
    Douglas J. Reding
    John Commins
    Craig Williams
    Meredith Yeager
    James K. Burmester
    Catherine Schairer
    Regina G. Ziegler
    Breast Cancer Research and Treatment, 2012, 133 : 785 - 792
  • [25] The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
    Daisuke Kawakita
    Yuan-Chin Amy Lee
    Lisa H Gren
    Saundra S Buys
    Carlo La Vecchia
    Mia Hashibe
    British Journal of Cancer, 2018, 118 : 299 - 306
  • [26] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [27] The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
    Kawakita, Daisuke
    Lee, Yuan-Chin Amy
    Gren, Lisa H.
    Buys, Saundra S.
    La Vecchia, Carlo
    Hashibe, Mia
    BRITISH JOURNAL OF CANCER, 2018, 118 (02) : 299 - 306
  • [28] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    McCarty, Catherine A.
    Reding, Douglas J.
    Commins, John
    Williams, Craig
    Yeager, Meredith
    Burmester, James K.
    Schairer, Catherine
    Ziegler, Regina G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 785 - 792
  • [29] No association between vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Hoyt, Maggie
    Reger, Michael
    Zhang, Jianjun
    CANCER RESEARCH, 2017, 77
  • [30] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10): : 722 - 731